stat-ins

Clinical-trials-after-COVID-19

Clinical trials after COVID-19

Clinical trials after COVID-19 558 344 Exploristics

Aiden Flynn, CEO 11 August 2020

The challenges faced by the Pharmaceutical Industry have been well documented: the high costs of clinical trials; the high rates of attrition; higher regulatory scrutiny; limited scope to pay high costs of new medicines; …

covid-19

Where there’s a will there’s a way

Where there’s a will there’s a way 558 344 Exploristics

Aiden Flynn, CEO 7 July 2020

The COVID-19 pandemic has demonstrated the importance of science and the dedication of scientists in overcoming the challenges that we face. At Exploristics, we have been involved in multiple projects relating to the development …

We are thrilled to announce that Exploristics is now part of MMS, a global data-focused CRO!

X